Advanced Hepatocellular Carcinoma

Also known as: Advanced Hepatocellular Carcinoma (HCC)

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB09037	Pembrolizumab	0	Terminated	1
DB12774	AZD-8055	1	Completed	1
DB00062	Albumin human	1	Suspended	1
DB11885	Anlotinib	1	Recruiting	1
DB11595	Atezolizumab	1	Recruiting	1
DB11595	Atezolizumab	1	Suspended	1
DB06626	Axitinib	1	Completed	1
DB00112	Bevacizumab	1	Recruiting	1
DB08875	Cabozantinib	1	Active Not Recruiting	1
DB08875	Cabozantinib	1	Suspended	1
DB11911	Galunisertib	1	Completed	1
DB15169	H3B-6527	1	Completed	1
DB12154	Itacitinib	1	Active Not Recruiting	1
DB18143	MTL-CEBPA	1	Recruiting	1
DB14375	Milk thistle	1	Completed	1
DB01204	Mitoxantrone	1	Not Yet Recruiting	1
DB09035	Nivolumab	1	Active Not Recruiting	1
DB09035	Nivolumab	1	Terminated	1
DB16630	OPB-111077	1	Terminated	1
DB01229	Paclitaxel	1	Suspended	1
DB16747	Penpulimab	1	Not Yet Recruiting	1
DB16747	Penpulimab	1	Recruiting	1
DB05210	SF1126	1	Terminated	1
DB15765	Sintilimab	1	Active Not Recruiting	1
DB15765	Sintilimab	1	Completed	1
DB06026	Tivantinib	1	Completed	1
DB12200	Tivantinib	1	Completed	1
DB06184	AEG35156	1 / 2	Completed	1
DB16412	Adebrelimab	1 / 2	Not Yet Recruiting	1
DB16412	Adebrelimab	1 / 2	Recruiting	1
DB00112	Bevacizumab	1 / 2	Not Yet Recruiting	1
DB16538	Bifidobacterium bifidum	1 / 2	Recruiting	1
DB11865	Brivanib alaninate	1 / 2	Terminated	1
DB15414	CM-4307	1 / 2	Recruiting	1
DB16680	Cadonilimab	1 / 2	Active Not Recruiting	1
DB14776	Camrelizumab	1 / 2	Recruiting	1
DB11791	Capmatinib	1 / 2	Completed	1
DB00445	Epirubicin	1 / 2	Unknown Status	1
DB00965	Ethiodized oil	1 / 2	Unknown Status	1
DB00305	Mitomycin	1 / 2	Unknown Status	1
DB11991	Oprozomib	1 / 2	Withdrawn	1
DB09037	Pembrolizumab	1 / 2	Recruiting	1
DB08896	Regorafenib	1 / 2	Active Not Recruiting	1
DB14765	Rivoceranib	1 / 2	Recruiting	1
DB00398	Sorafenib	1 / 2	Completed	1
DB00398	Sorafenib	1 / 2	Withdrawn	1
DB14892	Spartalizumab	1 / 2	Completed	1
DB16685	Tebotelimab	1 / 2	Terminated	1
DB17109	Tegavivint	1 / 2	Recruiting	1
DB15043	Toripalimab	1 / 2	Recruiting	1
DB11885	Anlotinib	2	Unknown Status	1
DB00112	Bevacizumab	2	Active Not Recruiting	1
DB00112	Bevacizumab	2	Completed	1
DB08875	Cabozantinib	2	Completed	1
DB08875	Cabozantinib	2	Terminated	1
DB14776	Camrelizumab	2	Not Yet Recruiting	1
DB01101	Capecitabine	2	Unknown Status	1
DB11791	Capmatinib	2	Withdrawn	1
DB11714	Durvalumab	2	Recruiting	2
DB00442	Entecavir	2	Recruiting	1
DB15769	Envafolimab	2	Completed	1
DB08899	Enzalutamide	2	Completed	1
DB15149	Futibatinib	2	Recruiting	1
DB16019	Gallium Ga-68 gozetotide	2	Recruiting	1
DB16303	Gallium-68 PSMA	2	Recruiting	1
DB09078	Lenvatinib	2	Active Not Recruiting	1
DB09078	Lenvatinib	2	Completed	2
DB09078	Lenvatinib	2	Not Yet Recruiting	1
DB09078	Lenvatinib	2	Recruiting	1
DB06080	Linifanib	2	Completed	1
DB06075	Linsitinib	2	Terminated	1
DB09035	Nivolumab	2	Completed	1
DB09035	Nivolumab	2	Enrolling by Invitation	1
DB00526	Oxaliplatin	2	Unknown Status	1
DB09073	Palbociclib	2	Active Not Recruiting	1
DB09037	Pembrolizumab	2	Active Not Recruiting	1
DB09037	Pembrolizumab	2	Recruiting	1
DB09037	Pembrolizumab	2	Terminated	1
DB16422	Quavonlimab	2	Active Not Recruiting	1
DB08896	Regorafenib	2	Recruiting	1
DB00073	Rituximab	2	Not Yet Recruiting	1
DB14765	Rivoceranib	2	Completed	1
DB14765	Rivoceranib	2	Not Yet Recruiting	1
DB17451	Serplulimab	2	Not Yet Recruiting	1
DB15765	Sintilimab	2	Unknown Status	1
DB00398	Sorafenib	2	Completed	2
DB00398	Sorafenib	2	Enrolling by Invitation	1
DB00398	Sorafenib	2	Not Yet Recruiting	1
DB00398	Sorafenib	2	Recruiting	1
DB00398	Sorafenib	2	Terminated	1
DB00398	Sorafenib	2	Unknown Status	1
DB09327	Tegafur-uracil	2	Terminated	1
DB15101	Tigatuzumab	2	Completed	1
DB14922	Tislelizumab	2	Completed	1
DB14922	Tislelizumab	2	Recruiting	2
DB15043	Toripalimab	2	Active Not Recruiting	1
DB12056	Trebananib	2	Completed	1
DB11771	Tremelimumab	2	Recruiting	1
DB03904	Urea	2	Recruiting	1
DB06791	Lanreotide	2 / 3	Completed	1
DB00104	Octreotide	2 / 3	Completed	1
DB11885	Anlotinib	3	Not Yet Recruiting	1
DB00112	Bevacizumab	3	Active Not Recruiting	1
DB14776	Camrelizumab	3	Recruiting	2
DB14776	Camrelizumab	3	Terminated	1
DB11714	Durvalumab	3	Recruiting	1
DB09078	Lenvatinib	3	Active Not Recruiting	1
DB09078	Lenvatinib	3	Not Yet Recruiting	1
DB09078	Lenvatinib	3	Recruiting	2
DB00104	Octreotide	3	Completed	1
DB06592	Pegargiminase	3	Recruiting	1
DB16747	Penpulimab	3	Not Yet Recruiting	1
DB08896	Regorafenib	3	Terminated	1
DB14765	Rivoceranib	3	Terminated	1
DB00398	Sorafenib	3	Active Not Recruiting	1
DB00398	Sorafenib	3	Not Yet Recruiting	1
DB00398	Sorafenib	3	Recruiting	1
DB00398	Sorafenib	3	Terminated	1
DB00398	Sorafenib	3	Unknown Status	1
DB15043	Toripalimab	3	Active Not Recruiting	2
DB11771	Tremelimumab	3	Recruiting	1
DB11595	Atezolizumab	Not Available	Completed	1
DB11595	Atezolizumab	Not Available	Recruiting	2
DB00112	Bevacizumab	Not Available	Completed	1
DB00112	Bevacizumab	Not Available	Not Yet Recruiting	1
DB00112	Bevacizumab	Not Available	Recruiting	2
DB15414	CM-4307	Not Available	Not Yet Recruiting	1
DB14776	Camrelizumab	Not Available	Recruiting	1
DB09078	Lenvatinib	Not Available	Withdrawn	1
DB15765	Sintilimab	Not Available	Recruiting	1
DB14922	Tislelizumab	Not Available	Recruiting	1
DB15043	Toripalimab	Not Available	Recruiting	1